However, Croyle found that these interactions were independent of the c-terminal moiety of RET which is inconsistent with our data and could be due to the different EGFR binding organization between RET fusion proteins in thyroid cancers and wild type RET in A+AD. The gene discussed is RET; the disease is thyroid gland carcinoma.